In cardiovascular monitoring, mobile cardiac telemetry (MCT) devices sit alongside Holter monitors and cardiac event monitors, each of which can be deployed as a skin patch. They allow for different levels of ambulatory monitoring, enabling at-risk patients to avoid the risks associated with remaining as an inpatient, but providing a higher quality of data that can be achieved by other devices such as a smartwatch.
In diabetes management, challenges in the markets around traditional self-monitoring of blood glucose via test strips are driving innovation. Leading players have developed continuous glucose monitoring devices (CGM) which can give a longer term picture of blood glucose levels, and are even achieving approval to work directly with insulin pumps, moving towards "closed-loop" systems. Both CGM devices and insulin pumps can be deployed using different types of skin patch, and are covered in detail in the report.
Electronic Skin Patches 2018-2028 covers both sections in detail, including details on product types, technology and a comparison of strategies from players in the space. The report includes a mixture of primary and secondary research, combining executive interviews, extensive conference visits and site visits with companies alongside supporting information from literature and other sources.
About the author:
James Hayward is Senior Technology Analyst at IDTechEx - www.IDTechEx.com/patches